Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syndevrx, Inc.filedCriticalSyndevrx, Inc.
Publication of HK40128362ApublicationCriticalpatent/HK40128362A/en
The present disclosure provides pharmaceutical combinations comprising MetAP2 inhibitors for the treatment of interstitial lung disease, including pulmonary fibrosis.
HK62025116706.5A2022-08-102023-08-10Metap2 inhibitors for the treatment of pulmonary fibrosis
HK40128362A
(en)